期刊文献+

5-HT2A受体基因多态性与奥氮平疗效的关联研究 被引量:4

Association of 5-HT2A receptor gene polymorphisms with the response to olanzapine in Chinese patients with schizophrenia
下载PDF
导出
摘要 目的 探讨广州地区汉族人群中5-HT2A受体A1438G和T102C基因多态性与奥氮平疗效的关系。方法 随机抽取143例精神分裂症患者,奥氮平单药治疗8周。治疗前后以阳性和阴性症状量表(PANSS)评定奥氮平临床疗效,按照PANSS减分率≥50%和〈50%分为有效组和无效组。采用聚合酶链反应-限制性片段长度多态性方法(PCR-RFLP)分析5-HT2A受体基因A1438G和T102C多态性。结果 (1)A1438G和T102C多态位点的基因型和等位基因在有效组和无效组之间分布均差异无显著性(P〉0.05);(2)治疗前A1438G不同基因型患者的阳性症状分及阴性症状分有显著性差异,携GG片段基因的患者阳性症状分为(22.3±2.9)分,显著低于AA型及AG型患者[(25.1±4.2)分;(25.9±3.6)分],而阴性症状分为(23.4±9.2)分,较AA型及AG型明显高;(3)经8周治疗后,携带AA型患者PANSS总减分率、阳性症状减分率、阴性症状减分率、一般精神病理症状减分率均比AG型和GG型患者减分率高,但差异无显著性;(4)各临床指标、PANSS分值及其减分率在T102C不同基因亚型间均差异无显著性(P〉0.05)。结论 5-HT2A受体A1438G和T102C基因多态性与广东地区汉族人群奥氮平疗效不存在关联,但GG基因型可能与精神分裂症的阴性症状严重程度有正关联,而与阳性症状严重程度成负关联。 Objective To investigate the possible association of 5-HT2A receptor gene A1438G and T102C polymorphisms with the response to olanzapine in Chinese patients with schizophrenia. Methods The recruited one hundred and forty-three schizophrenic patients were treated with olanzapine monotherapy for 8 weeks. The patients were evaluated regarding the clinical improvement using the Positive and Negative Syndrome Scale(PANSS) before and 8 weeks after olanzapine administration, and divided into groups of responders and non-responders according to the PANSS reductive rate. The 5-HT2A receptor gene A1438G and T102C polymorphisms were determined by PCR-restriction fragment length polymorphism (PCR-RFLP). Results No significant differences in genotype and allele frequencies of Ald38G and C102T polymorphisms in 5-HT2A receptor gene were observed between the responders and non-responders( P 〉0.05 ) ; the PANSS positive subscale score of pretreatment was sig- nificantly lower in patients with GG genotype (22.3 ± 2.9) than those with AA and AG (25.1 ± 4. 2 and 25.9 ± 3.6 respectively), however, the negative subscale score is significantly higher in patients with GG genotype(23.4 ± 9.2) than those with AA and AG, after 8 weeks' olanzapine treatment, patients with AA genotype have moderate higher PANSS reductive rates compared with those with AG and GG genotypes, but not significantly. There is no difference in PANSS score and its reductive rate among three genotypes of T102C polymorphism. Conclusion Our results showed that 5-HT2A receptor A1438G and C102T gene polymorphisms may not be associated with olanzapine' s response in the Han Chinese population in Guangdong district; GG genotype may be positively associated with the severe degree of positive symptoms but reversibly with negative symptoms of schizophrenia.
出处 《中国行为医学科学》 CSCD 2007年第3期202-204,共3页 Chinese Journal of Behavioral Medical Science
基金 广东省医学科研基金资助项目(B2003127)
关键词 5-HT2A受体基因 精神分裂症 奥氮平 药物遗传学 5-HT2A receptor gene Schizophrenia Olanzapine Pharmacogenetics
  • 相关文献

参考文献15

  • 1Arranze MJ, Munro J,Owren MJ, et al. Evidence for an association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Molecular Psychiatry, 1998,3: 61-66.
  • 2Yu YW, Tsai SJ, yang KH, et al. Evidence for an association between polymorphism of the seretonin-2A receptor variant(102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine. Neuropsychobiology,2001 ,43 : 79-82.
  • 3王刚,舒良,范建华,蔡焯基.利培酮临床治疗效应与5-HT_(2A)受体基因启动子多态性的关系[J].中国临床药理学杂志,2000,16(5):353-355. 被引量:14
  • 4Lin CH, Tsai SJ, Yu YW,et al. No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population. Neuroreport, 1999,10:57-60.
  • 5Chen CH, Lee YR, Wei FC,et al. Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese. Psychiatr Genet, 1997,7:35-38.
  • 6Senel Tot, M. Emin Erdal, Kemal Yazici, et al. T102C and -1438G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obessive-compulsive disorder. European Psychiatry,2003,18:249-254.
  • 7Ene-Choo Tan, Siow-Ann Chong, Rathi Mahendran, et al. Susceptibility to Neuroleptic-induced Tardive Dyskinesia and the T102C Polymorphism in the Serotonin Type 2A Receptor. Biol Psychiatry, 2001,50: 144-147.
  • 8马兆峰,陈希,庄晓华,张立亮.奥氮平对精神分裂症患者疗效及生活质量的影响[J].中国行为医学科学,2005,14(8):723-724. 被引量:8
  • 9戴俊平,赵振环,麦桂英,丁国安,何柱国,薜立庆.奥氮平与氯氮平对精神分裂症患者的疗效及生活质量影响的对照研究[J].中国行为医学科学,2004,13(4):396-398. 被引量:7
  • 10Basele VS, MarioMasellis. Pharmacogenomics in schizophrenia: the quest for individualized therapy. Human Molecular Genetics, 2002, 11 : 2517-2530.

二级参考文献14

  • 1王长虹,冯砚国,王来海.奥氮平与氯氮平治疗精神分裂症的双盲对照研究[J].上海精神医学,2002,14(3):143-145. 被引量:13
  • 2王蕾,李凌江,杨德森,郝伟.社区精神分裂症病人生活质量对照研究[J].中国心理卫生杂志,1996,10(4):145-147. 被引量:147
  • 3沈渔邨.精神病学.第2版.北京:人民卫生出版社,2002.197.
  • 4吴文源.临床疗效总评量表CGI.见:张明园,主编.精神科评定量表手册.长沙:湖南科学技术出版社,1993.151-154.
  • 5朱昌明.副反应量表TESS. 见:张明园,主编.精神科评定量表手册.长沙:湖南科学技术出版社,1993.198-203.
  • 6World Health Organization.WHOQOL~Bref introduction,administration, scoring and generic version of the assessment,field trial version. Programme on Mental Health. WHO:Geneva,1996.1-11.
  • 7Meltzer HY, Burnett S, Bastani B, et al. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Comm Psychiatry,1990,41:892-897.
  • 8Bhana N, Foster RH, Olney R, et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs,2001,61(1):111-161.
  • 9Ritchie CW, Chiu E, Harrigan S, et al. The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics in elderly patients with schizophrenia. Int J Geriatr Psychiatry,2003,18(5):432-440.
  • 10沈渔邨.精神病学(第2版)[M].北京:人民卫生出版社,1992.260-261.

共引文献26

同被引文献46

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部